73.24EUR+0.73%Mkt Cap: 88.60B EURP/E: 18.68Last update: 2026-05-14
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelit…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)18.68
P/E (Forward)8.21
PEG3.68
P/B1.22
P/S1.87
EV/EBITDA8.10
EV/Revenue2.19
EPS (TTM)3.96
EPS (Forward)9.00
Cash Flow & Leverage
FCF Yield18.82%
FCF Margin35.21%
Operating CF10.75B EUR
CapEx (TTM)3.54B EUR
Net Debt/EBITDA1.13
Net Debt14.48B EUR
Technical
SMA 5078.57 (-6.8%)
SMA 20081.89 (-10.6%)
Beta0.28
S&P 52W Chg24.23%
Avg Vol (30d)2.30M
Avg Vol (10d)2.44M
Technical Indicators
RSI (14)33.1
MACD-1.9260
MACD Signal-1.3524
MACD Hist.-0.5736
BB Upper84.59 EUR
BB Middle77.54 EUR
BB Lower70.49 EUR
BB Width18.18%
ATR (14)1.888 EUR
Vol Ratio (20d)1.01x
52W Range
72.533% of range94.10
52W High94.10 EUR
52W Low72.53 EUR
Profitability
Gross Margin72.07%
EBITDA Margin27.09%
Profit Margin16.72%
Oper. Margin20.00%
ROE10.95%
ROA6.16%
Revenue Growth6.00%
Earnings Growth-11.70%
Balance Sheet
Debt/Equity0.28
Current Ratio1.00
Quick Ratio0.20
Book Value/Sh60.46 EUR
Cash/Share4.604 EUR
Dividends
Fwd Div Rate4.120 EUR
Trail. Div Rate0.0000 EUR
Div. Yield5.57%
5Y Avg Yield3.94%
Payout Ratio98.99%
Ex-Div DateMay 5, 2026
Pay Date—
Ownership
Shares Out.1.20B
Float1.09B
Insiders10.27%
Institutions40.64%
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)97.10 EUR
Target Range82.00 EUR – 112.00 EUR
# Analysts23
Company
Market Cap88.60B EUR
Enterprise Value103.87B EUR
Revenue (TTM)47.35B EUR
Gross Profit33.67B EUR
Net Income (TTM)7.81B EUR
Revenue/Share39.04 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees74.8K
Last Price73.24 EUR
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000120578